Oral submucous fibrosis: pathogenesis and therapeutic approaches
Top Cited Papers
Open Access
- 1 February 2025
- journal article
- review article
- Published by Springer Nature in International Journal of Oral Science
- Vol. 17 (1) , 1-15
Abstract
Oral submucous fibrosis (OSF), characterized by excessive deposition of extracellular matrix (ECM) that causes oral mucosal tissue sclerosis, and even cancer transformation, is a chronic, progressive fibrosis disease. However, despite some advancements in recent years, no targeted antifibrotic strategies for OSF have been approved; likely because the complicated mechanisms that initiate and drive fibrosis remain to be determined. In this review, we briefly introduce the epidemiology and etiology of OSF. Then, we highlight how cell-intrinsic changes in significant structural cells can drive fibrotic response by regulating biological behaviors, secretion function, and activation of ECM-producing myofibroblasts. In addition, we also discuss the role of innate and adaptive immune cells and how they contribute to the pathogenesis of OSF. Finally, we summarize strategies to interrupt key mechanisms that cause OSF, including modulation of the ECM, inhibition of inflammation, improvement of vascular disturbance. This review will provide potential routes for developing novel anti-OSF therapeutics.Keywords
This publication has 214 references indexed in Scilit:
- Emerging role of cellular senescence in the pathogenesis of oral submucous fibrosis and its malignant transformationHead & Neck, 2021
- Angiotensin (1–7) inhibits arecoline‐induced migration and collagen synthesis in human oral myofibroblasts via inhibiting NLRP3 inflammasome activationJournal of Cellular Physiology, 2018
- Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosisHepatology, 2018
- Areca nut exposure increases secretion of tumor‐promoting cytokines in gingival fibroblasts that trigger DNA damage in oral keratinocytesInternational Journal of Cancer, 2015
- Senescent mesenchymal cells accumulate in human fibrosis by a telomere‐independent mechanism and ameliorate fibrosis through matrix metalloproteinasesThe Journal of Pathology, 2010
- Betel‐derived alkaloid up‐regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosisThe Journal of Pathology, 2010
- Human oral cancers have altered expression of Bcl‐2 family members and increased expression of the anti‐apoptotic splice variant of Mcl‐1The Journal of Pathology, 2008
- Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral submucous fibrosisIndian Journal of Clinical Biochemistry, 2004
- PLS‐ANN based classification model for oral submucous fibrosis and oral carcinogenesisLasers in Surgery and Medicine, 2003
- Role of areca nut consumption in the cause of oral cancers. A cytogenetic assessmentCancer, 1992